Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Australia / NCT07874139
Recruiting Observational

Prospective Study on Antimicrobial RESIstance in Chronic Pulmonary DiseasE

NCT07874139 · tracked via the Priya Life Science Australia tracker
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Phase
Observational
Started
2025-03-31
Last updated
2026-10-14

Condition(s) studied

Chronic Lung Diseases

Study summary

This observational, multicentric prospective study aims to understand the prevalence and burden of antimicrobial resistance (AMR) in people with chronic lung diseases (CLD) across the globe, understanding also geographical variability and the risk factors for acquiring AMR.

The primary objective is to understand the prevalence and burden of AMR in CLD both at a local and gloval level.

Secondary objectives include: 1) understanding susceptibilities models of high priority pathogens in people with CLD; 2) understanding geographic variability in the prevalence of AMR in CLD; 3) analysing risk factors for AMR in CLD Participants will be recruited

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients of all ages with any chronic lung disease who, for clinical practice, underwent testingof at least one respiratory biological sample (sputum culture; bronchoaspirate; bronchoalveolar lavage; nasal swab; throat swab) within the 12 months prior to the visit. * Patients attending an outpatient clinic or hospitalized during the study period Exclusion Criteria: * Patients who have not signed the informed consent form * Absence of data in the patient record

Primary outcome measure(s)

  • Prevalence of antimicrobial resistance in chronic lung diseases — Five years from the beginning of the study.
    Prevalence and burden of antimicrobial resistance in chronic lung diseases at both local and global levels.

Trial sites (68)

FacilityCityRegionStatus
University of Michigan Ann Arbor Michigan Recruiting
Catholic University Our Lady of Good Counsel Tirana Albania Recruiting
Frankston Hospital Frankston Australia Recruiting
Antwerp University Hospital Antwerp Belgium Recruiting
CHU St Pierre Brussels Belgium Recruiting
AZ Maria Middelares Ghent Belgium Recruiting
Ghent University Hospital Ghent Belgium Recruiting
University Hospital Leuven Leuven Belgium Recruiting
Santa Casa de Belo Horizonte Minas Gerais Brazil Recruiting
Foothills Medical Centre Calgary Canada Recruiting
Hangzhou Red Cross Hospital Hangzhou China Recruiting
Dubrava University Hospital Zagreb Croatia Recruiting
2nd Faculty of Medicine, Charles University and Motol University Hospital Prague Czechia Recruiting
Zealand University Hospital - Roskilde and Naestved Copenhagen Denmark Recruiting
Assiut University Hospital Asyut Egypt Recruiting
Al Hussein University Hospital Cairo Egypt Recruiting
Centre Hospitalier Universitaire de Reims Reims France Recruiting
Charité - Universitatmedizin Berlin Berlin Germany Recruiting
University Clinic Marburg Marburg Germany Recruiting
General Hospital "Papanikolaou" Thessaloniki Greece Recruiting
The University of Hong Kong, Pok Fu Lam Hong Kong Hong Kong Recruiting
GCS Medical College Hospital and Research Centre Ahmedabad India Recruiting
AIIMS (All India Institute of Medical Science) Dehli India Recruiting
Aster Medcity Kochi India Recruiting
Calcutta Medical Research Institute Kolkata India Recruiting
Policlinico S Orsola - Malpighi Bologna Italy Recruiting
ULSS3 Serenissima Ospedale di Dolo Dolo Italy Recruiting
AOU Policlinico Universitario G Martino Messina Italy Recruiting
ASST Santi Paolo e Carlo Milan Italy Active Not Recruiting
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano Milan Italy Recruiting
IRCCS Humanitas Research Hospital Milan Italy Recruiting
IRCCS San Gerardo dei Tintori Monza Italy Recruiting
Kathmandu Medical College Kathmandu Nepal Recruiting
Nigeria Centre for Disease Control and Prevention Abuja Nigeria Recruiting
General Hospital 8th September Skopje North Macedonia Recruiting
Aga Khan University Karachi Pakistan Recruiting
Instytut Gruzlicy i Chorob Pluc Warsaw Poland Recruiting
Hospital de Santa Maria, Centro Ospitalar Lisboa Norte EPE Lisbon Portugal Recruiting
University Clinical Centre Nis Niš Serbia Recruiting
University Clinic of Respiratory and Allergic Diseases Golnik Slovenia Recruiting

+ 28 more sites — see the full list on the official registry below.

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07874139 on ClinicalTrials.gov ↗ ← All trials in Australia